Skip to main content
. 2021 Jan 8;9(1):56. doi: 10.3390/biomedicines9010056

Table 1.

NB1 protein expression and platinum resistance in sporadic ovarian cancer.

NBS Protein Expression (Nuclear) p-Value
Low High 0.0001
Sensitive 131 (74.9%) 44 (25.1%)
Resistant * 5 (31.3%) 11 (68.8%)
NBS Protein Expression (Cytoplasmic) p-Value
Low High 0.676
Sensitive 97 (55.4%) 78 (44.6%)
Resistant * 8 (50%) 8 (50%)

* = Platinum resistance was defined as patients who had progression during first-line platinum chemotherapy or relapse within 6 months after completion of chemotherapy.